Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.

<h4>Purpose</h4>To assess the long-term treatment outcomes of dry eye in patients with and without underlying primary Sjögren's syndrome (SS).<h4>Design</h4>Retrospective longitudinal cohort.<h4>Methods</h4>SS and non-SS dry eye patients with clinic visits fo...

Full description

Saved in:
Bibliographic Details
Main Authors: David Cui, Priya Mathews, Gavin Li, Shanna VanCourt, Esen Akpek
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261241&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850074994064752640
author David Cui
Priya Mathews
Gavin Li
Shanna VanCourt
Esen Akpek
author_facet David Cui
Priya Mathews
Gavin Li
Shanna VanCourt
Esen Akpek
author_sort David Cui
collection DOAJ
description <h4>Purpose</h4>To assess the long-term treatment outcomes of dry eye in patients with and without underlying primary Sjögren's syndrome (SS).<h4>Design</h4>Retrospective longitudinal cohort.<h4>Methods</h4>SS and non-SS dry eye patients with clinic visits for a minimum of 5 consecutive years at a tertiary, dedicated dry eye clinic were included. Electronic health records were reviewed to collect data regarding demographics, objective dry eye parameters, treatments utilized at baseline and final visit, and corneal complications observed during follow-up.<h4>Results</h4>Two hundred and two patients (101 SS and 101 randomly selected non-SS), with a mean follow-up of 7.1 years were included. At baseline, mean conjunctival lissamine green staining score was 2.9 and mean corneal fluorescein staining score was 2.0. At last visit, notable improvement in staining score for cornea (-1.1, P < .001) and conjunctiva (-1.8, P < .001) was seen equally in both dry eye groups. Most patients (88.1%) had an escalation of treatment by the final visit, with similar rates in both groups (P = .51). Half (48.9%) of the patients had no conjunctival staining, and a third (34.4%) had no corneal staining at their last visit. Twenty (9.9%) patients experienced a vision-threatening corneal complication, including ulcers and melt, with no difference in occurrences between the groups (P = .64).<h4>Conclusions</h4>The majority of patients in this longitudinal, tertiary clinic-based sample demonstrated improvement in their ocular surface staining score by the final visit with escalation in treatment. Treatments used, improvement achieved, and corneal complication rates leading to loss of vision were similar in both SS and non-SS dry eye groups.
format Article
id doaj-art-710ad4c8424e4241a30d4efe7e0887e3
institution DOAJ
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-710ad4c8424e4241a30d4efe7e0887e32025-08-20T02:46:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-011612e026124110.1371/journal.pone.0261241Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.David CuiPriya MathewsGavin LiShanna VanCourtEsen Akpek<h4>Purpose</h4>To assess the long-term treatment outcomes of dry eye in patients with and without underlying primary Sjögren's syndrome (SS).<h4>Design</h4>Retrospective longitudinal cohort.<h4>Methods</h4>SS and non-SS dry eye patients with clinic visits for a minimum of 5 consecutive years at a tertiary, dedicated dry eye clinic were included. Electronic health records were reviewed to collect data regarding demographics, objective dry eye parameters, treatments utilized at baseline and final visit, and corneal complications observed during follow-up.<h4>Results</h4>Two hundred and two patients (101 SS and 101 randomly selected non-SS), with a mean follow-up of 7.1 years were included. At baseline, mean conjunctival lissamine green staining score was 2.9 and mean corneal fluorescein staining score was 2.0. At last visit, notable improvement in staining score for cornea (-1.1, P < .001) and conjunctiva (-1.8, P < .001) was seen equally in both dry eye groups. Most patients (88.1%) had an escalation of treatment by the final visit, with similar rates in both groups (P = .51). Half (48.9%) of the patients had no conjunctival staining, and a third (34.4%) had no corneal staining at their last visit. Twenty (9.9%) patients experienced a vision-threatening corneal complication, including ulcers and melt, with no difference in occurrences between the groups (P = .64).<h4>Conclusions</h4>The majority of patients in this longitudinal, tertiary clinic-based sample demonstrated improvement in their ocular surface staining score by the final visit with escalation in treatment. Treatments used, improvement achieved, and corneal complication rates leading to loss of vision were similar in both SS and non-SS dry eye groups.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261241&type=printable
spellingShingle David Cui
Priya Mathews
Gavin Li
Shanna VanCourt
Esen Akpek
Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.
PLoS ONE
title Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.
title_full Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.
title_fullStr Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.
title_full_unstemmed Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.
title_short Outcomes of Sjögren's versus non-Sjögren's related dry eye in a longitudinal, tertiary clinic-based sample.
title_sort outcomes of sjogren s versus non sjogren s related dry eye in a longitudinal tertiary clinic based sample
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0261241&type=printable
work_keys_str_mv AT davidcui outcomesofsjogrensversusnonsjogrensrelateddryeyeinalongitudinaltertiaryclinicbasedsample
AT priyamathews outcomesofsjogrensversusnonsjogrensrelateddryeyeinalongitudinaltertiaryclinicbasedsample
AT gavinli outcomesofsjogrensversusnonsjogrensrelateddryeyeinalongitudinaltertiaryclinicbasedsample
AT shannavancourt outcomesofsjogrensversusnonsjogrensrelateddryeyeinalongitudinaltertiaryclinicbasedsample
AT esenakpek outcomesofsjogrensversusnonsjogrensrelateddryeyeinalongitudinaltertiaryclinicbasedsample